Pharmabiz16h
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova
(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and sell an experimental cancer drug, the two companies said on ...
Pharmabiz9h
CPHI & PMEC India to showcase innovation & sustainability
As a significant milestone in India's pharma sector, the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26 to 28, 2024 ...
Le Lézard9h
Trimble receives expected delisting and deficiency notice from Nasdaq
at 06:50 Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd. Merck , known as MSD outside of the United States and ...
The New York Times1d
New York Times - Top Stories
G.O.P. Wins the House, and Control of Congress BREAKING Sweep Gives Trump and His Party a Governing Trifecta The party protected vulnerable incumbents and picked off Democrats in competitive ...